Anti-SUMO4 Antibody

This polyclonal reagent from Antibodies.com targets SUMO4 (Small Ubiquitin-like Modifier 4), a ubiquitin-like protein implicated in post-translational modification and linked through genetic studies to type 1 diabetes susceptibility. Raised in rabbit and supplied unconjugated at 100 µl per vial, the antibody is validated for Western blot and immunohistochemistry workflows, supporting detection of endogenous SUMO4 in lysates and tissue sections.

Cross-reactivity has been confirmed against human, mouse, and rat samples, making the reagent useful across comparative model systems. Recommended uses include Western blot analysis of SUMO-conjugated substrates, IHC localisation studies in pancreatic and immune-relevant tissues, and follow-up confirmation of expression changes in cellular and animal models of inflammatory or autoimmune disease.

Provided as a liquid polyclonal antiserum fraction, the antibody is intended for research use only and suits laboratories studying SUMOylation pathways, stress-response signalling, and the molecular genetics of immune-related disorders.